Brookfield Asset Management is awaiting information from Grifols SA about related-party transactions as it seeks to complete ...

EST Brookfield still pursuing Grifols (GRFS) deal, Bloomberg reports Published first on TheFly – the ultimate source for ...

Brookfield Asset Management (BAM) is awaiting information from Grifols (GRFS) about related-party transactions as it seeks to complete its due ...

Grifols (NASDAQ:GRFS) rose 4% after a report that Brookfield Asset Management (BAM) is still evaluating a takeover of the ...

As global markets grapple with rising Treasury yields and tepid economic growth, investors are increasingly focused on identifying stocks that may be trading below their intrinsic value. In this ...

The rising prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal disorders is a key driver behind this market expansion. Patients with these conditions often require parenteral ...

Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to ...

Berenberg Bank upgraded shares of Grifols (NASDAQ:GRFS – Free Report) to a strong-buy rating in a report released on Tuesday, Zacks.com reports. Grifols Price Performance Shares of NASDAQ GRFS opened ...

Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasis Grifols surgical bleeding management ...

BARCELONA - Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), the global healthcare company known for its plasma-derived medicines, has received U.S. FDA approval for its Fibrin Sealant (FS) for use in ...